Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 2, 2024

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More
Page1 Page2 Page3 … Page7
RECENT POSTS

WHO Warns Of A Record-breaking Ebola Outbreak In Congo

August 13, 2026

Conflict-Displaced Women in Eastern DRC Face Increasing Sexual Violence Risk

August 13, 2026

Ebola Outbreak in Eastern DR Congo Claims Over 300 Children; New Vaccine Trials Recommended

August 7, 2026

DR Congo Ebola Outbreak Surpasses 4,000 Cases Amidst Expanding Health Response

August 7, 2026

Ebola Cases Surpass 4,000 in Democratic Republic of Congo

August 7, 2026

Antwerp Confronts Colonial Past with Monument to Human Zoo Victims

August 7, 2026

Ebola Death Toll Tops 1,800 in DRC

August 7, 2026

DRCs Largest Ebola Outbreak on Record: Active Conflict and Armed Groups Hamper the Response

August 7, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.